Age dependent accumulation of N-acyl-ethanolamine phospholipids in ischemic rat brain: A 31P NMR and enzyme activity study

Journal of Lipid Research

Volumn 41, Issue 6, 2000, Pages 985-990

  Moesgaard, Birthe ^a   Petersen, Gitte ^a   Jaroszewski, Jerzy W ^a   Hansen, Harald S ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

31P NMR; Anandamide; Ischemia; N acyl ethanolamine phospholipid hydrolyzing phospholipase D; N acyltransferase; Rat brain development

Indexed keywords

ACYLTRANSFERASE; ETHANOLAMINE DERIVATIVE; PHOSPHOLIPASE D; PHOSPHOLIPID DERIVATIVE;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; BRAIN ISCHEMIA; BRAIN MICROSOME; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; LIPID ANALYSIS; MALE; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RAT;

ACYLTRANSFERASES; AGING; ANIMALS; BRAIN ISCHEMIA; ENDOCANNABINOIDS; HYDROLYSIS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PHOSPHATIDYLETHANOLAMINES; PHOSPHOLIPASE D; PHOSPHORUS ISOTOPES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033919878     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Hansen, H. S., L. Lauritzen, B. Moesgaard, A. M. Strand, and H. H. Hansen. 1998. Formation of N-acyl-phosphatidylethanolamines and N-acylethanolamines - proposed role in neurotoxicity. Biochem. Pharmacol. 55: 719-725.
2. Schmid, H. H. O., P. C. Schmid, and V. Natarajan. 1990. N-acylated glycerophospholipids and their derivatives. Prog. Lipid Res. 29: 1-43.
3. Choi, D. W., D. Lobner, and L. L. Dugan. 1998. Glutamate receptor-mediated neuronal death in the ischemic brain. Monogr. Clin. Neurosci. 16:2-13.
4. Ikonomidou, C., J. L. Mosinger, K. S. Salles, J. Labruyere, and J. W. Olney. 1989. Sensitivity of the developing rat brain to hypobaric/ ischemic damage parallels sensitivity to N-methyl-aspartate neurotoxicity. J. Neurosci. 9: 2809-2818.
5. Hansen, H. S., L. Lauritzen, A. M. Strand, A. M. Vinggaard, A. Frandsen, and A. Schousboe. 1997. Characterization of glutamate-induced formation of N-acylphosphatidylethanolamine and N-acylethanolamine cultured neocortical neurons. J. Neurochem. 69:753-761.
6. Hansen, H. S., B. Moesgaard, H. H. Hansen, A. Schousboe, and G. Petersen. 1999. Formation of N-acyl-phosphatidylethanolamine and N-acylethanolamine (including anandamide) during glutamate-induced neurotoxicity. Lipids 34 Suppl.: 327-330.
7. Hansen, H. S., L. Lauritzen, A. M. Strand, B. Moesgaard, and A. Frandsen. 1995. Glutamate stimulates the formation of N-acylphosphatidylethanolamine and N-acylethanolamine in cortical neurons in culture. Biochim. Biophys. Acta. 1258: 303-308.
8. Nagayama, T., A. D. Sinor, R. P. Simon, J. Chen, S. H. Graham, K. L. Jin, and D. A. Greenberg. 1999. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J. Neorosci. 19: 2987-2995.
9. Shen, M. X., and S. A. Thayer. 1998. Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity. Mol. Pharmacol. 54: 459-462.
10. 2+-dependent transacylase and phosphodiesterase activities. Biochem. Biophys. Res. Commun. 218: 113-117.
11. Sugiura, T., S. Kondo, A. Sukagawa, T. Tonegawa, S. Nakane, A. Yamashita, Y. Ishima, and K. Waku. 1996. Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes-comparison with synthesis from free arachidonic acid and ethanolamine. Eur. J. Biochem. 240: 53-62.
12. Hillard, C. J., and W. B. Campbell. 1997. Biochemistry and pharmacology of arachidonylethanolamide, a putative endogenous cannabinoid. J. Lipid Res. 38: 2383-2398.
13. Mechoulam, R., E. Fride, and V. Di Marzo. 1998. Endocannabinoids. Eur. J. Pharmacol 359: 1-18.
14. Cadas, H., E. Di Tomaso, and D. Piomelli. 1997. Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. J. Neurosci. 17: 1226-1242.
15. Natarajan, V., P. C. Schmid, and H. H. O. Schmid. 1986. N-acylethanolamine phospholipid metabolism in normal and ischemic rat brain. Biochim. Biophys. Acta. 878: 32-41.
16. 31P NMR study. J. Lipid Res. 40: 515-521.
17. Folch, J., M. Lees, and G. H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J Biol. Chem. 226: 497-509.
18. 31P NMR in the analysis of extracted tissue phospholipids. In Phosphorus-31 NMR Spectral Properties in Compound Characterization and Structural Analysis. L. D. Quin and J. G. Verkade, editors. VCH Publishers, Inc., New York. 283-294.
19. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye-binding. Anal. Biochem. 72: 248-254.
20. Schmid, P. C., P. V. Reddy, V. Natarajan, and H. H. O. Schimid. 1983. Metabolism of N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type. J. Biol. Chem. 258: 9302-9306.
21. Deutsch, D. G., and S. A. Chin. 1993. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem. Pharmacol. 46:791-796.
22. Petersen, G., and H. S. Hansen. 1999. N-acylphosphatidylethanolamine-hydrolysing phospholipase D lacks the ability to transphosphatidylate. FEBS Lett. 455: 41-44.
23. Domingo, J. C., M. Mora, and M. Africa de Madariaga. 1994. Role of headgroup structure in the phase behaviour of N-acylethanolamine phospholipids: hydrogen-bonding ability and headgroup size. Chem. Phys. Lipids. 69: 229-240.
24. Newman, J. L., D. L. Stiers, W. H. Anderson, and H. H. O. Schmid. 1986. Phase behaviour of synthetic N-acylethanolamine phospholipids. Chem. Phys. Lipids. 42: 249-260.
25. Ameri, A., A. Wilhelm, and T. Simmet. 1999. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices. Br. J. Pharmacol. 126: 1831-1839.
26. 2+ release from mitochondria by N-acylethanolamines, a class of lipids synthesized in ischemic heart tissue. J. Biol. Chem. 257: 1383-1391.
27. Gulaya, N. M., A. I. Kuzmenko, V. M. Margitich, N. M. Govseeva, S. O. Melnichuk, T. M. Goridko, and A. D. Zhukov. 1998. Long-chain N-acylethanolamines inhibit lipid peroxidation in rat liver mitochondria under acute hypoxic hypoxia. Chem. Phys. Lipids. 97: 49-54.
28. Skaper, S. D., A. Buriani, R. Dal Toso, L. Petrelli, S. Romanello, L. Facci, and A. Leon. 1996. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc. Natl. Acad. Sci. USA. 93: 3984-3989.
29. Polil, D., P. Bittigau, M. J. Ishimaru, D. Stadthaus, C. Hübner, J. W. Olney, L. Turski, and C. Ikonomidou. 1999. N-methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain. Proc. Natl Acad. Sci. USA. 96: 2508-2513.
30. Schmid, P. C., R. J. Krebsbach, S. R. Perry, T. M. Dettmer, J. L. Maasson, and H. H. O. Schmid. 1995. Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain. FEBS Lett. 375: 117-120.